StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Pre-Open Stock Movers 03/22: (HIBB) (SRNE) (LITE) Higher; (CNAT) (ZUO) (CAL) Lower (more...)
March 22, 2019 9:21 AM
Today's Pre-Open Movers:Conatus Pharmaceuticals Inc. (NASDAQ: CNAT) 56% LOWER; announced top-line results from the companys Phase 2b ENCORE-NF clinical trial ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Special Reports
Next Articles
Sorrento Therapeutics (SRNE) Subsidiary Scilex Holdings Reports Phase 2 Trial Results for its Leading SP-102 Program
March 26, 2019 8:33 AM
Hibbett Sports (HIBB) PT Raised to $22 at Canaccord Genuity Following 4Q
March 25, 2019 8:20 AM